Stay updated on IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.

Latest updates to the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoChange DetectedThe study description has been updated to remove specific details about the patient population, changing from previously treated RAS-mutant tumors to a more general focus on advanced or metastatic solid tumors. Additionally, the date has been updated from February 19, 2025, to April 22, 2025.SummaryDifference1%
- Check23 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with 'Here’s how you know' in a different format.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-19.SummaryDifference1.0%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.